Equillium Statistics
NASDAQ: EQHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.40-0.04 (-2.76%)
Market open · Delayed 15 min · as of Oct 9, 10:22 AM ET
Equillium by the numbers
Equillium has a market capitalization of $88.8 million based on 63.41M shares outstanding. With trailing EPS of $-0.14, Equillium is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 31.9% below its 50-day average and 32.7% below its 200-day average.
Average daily trading volume is 583.72K shares, or about $817,201 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
EQ valuation vs. peer median
| Metric | EQ | Peer median | Difference |
|---|---|---|---|
| Market cap | $88.77M | $90.42M | -2% |
| Avg. volume | 583.72K | 99.15K | +489% |
Peer median across 8 companies: MIST, SDEV, RLYB, CTOR, OKUR, PMN, TELO, PLYX.
Valuation
- Market cap
- $88.77M
- EPS (TTM)
- $-0.14
- Shares outstanding
- 63.41M
Price and trading
- Previous close
- 1.44
- Open
- 1.45
- Day range
- 1.38 – 1.46
- 52-week range
- 0.76 – 3.54
- 52-week change
- -2.04%
- Beta
- —
- Volume
- 120.31K
- Average volume
- 583.72K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 88.77M
- Forward Pe
- -5.98
- Eps
- -0.14
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.54
- Week52 Low
- 0.76
- Avg Volume
- 583.72K
- Shares Outstanding
- 63.41M
- Ma50
- 2.05
- Ma200
- 2.08
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -60.45%
- Pct From52w Low
- 84.21%